AlphAIAlphAI — Financial news for AI agents
investing.com$HUM

Humana earnings beat by $0.30, revenue topped estimates

Humana (HUM) reported Q3 EPS of $-0.70, beating estimates by $0.30, with revenue at $41.16B, exceeding expectations. The company forecasted FY 2026 EPS of $9.50, higher than analyst consensus. Shares are up 6.96% in 3 months and 63.38% in 12 months.

Original reporting
investing.com
Published Nov 6, 2026, 11:16 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 11:39 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$HUM
Bullish
high confidence
Mentioned
$HUM
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$HUMBullishHigh
01

Why it matters

The earnings beat and raised guidance suggest stronger-than-expected enrollment and cost management, supporting a bullish outlook.

02

Market read

Humana's strong Q3 results could lift the broader health insurance sector and influence investor sentiment on related stocks.

03

What to watch

Potential headwinds from regulatory changes or rising medical cost inflation could temper upside.

Relevance 8/10Novelty 8/10Timing: today

Background

Humana is a major U.S. health insurer; its earnings release is closely watched for insights into healthcare spending trends.

Company-level read

Ticker impact

$HUMBullishHigh confidence
Context

Humana reported Q3 EPS of -$0.70 beating estimates by $0.30 and raised FY 2026 EPS guidance to $9.50.

Expected impact

potential upside as investors price in the earnings beat and higher guidance

Evidence & confidence

The beat and guidance lift expectations for profitability, prompting short-term bullish sentiment.

Market effects

Sector

Health insurance sector may see broader rally on stronger earnings trends.

Regional

U.S. market could see modest gains in healthcare stocks.

Global

Limited to U.S. investors; no immediate global impact.

Counterpoint

What could challenge this read

If the beat is already priced in, the stock could face short-covering pullback.

Key entities

  • company
    Humana

    U.S.-listed health insurance provider (NYSE: HUM).

Read at source← All news

StoryHumana posts Q3 2026 results and lifts FY2026 adjusted EPS guidance to at least $9.50

Also covered by

6 outlets

Related articles

$HUMHighAI 8/10

Humana Raises Profit Floor on Lower Costs

Humana (HUM) raised its 2026 adjusted earnings guidance to at least $9.50 per share from $9.00, citing lower costs. Q3 insurance benefit ratio was 93.7%, better than expected. Shares fell 0.59% in pre-market trading. Humana's Medicare Advantage membership grew 23% this year.

asktraders.com
$HUMHighAI 8/10

HUM Q3 FY2026 earnings call

Humana Inc. reported Q3 2026 earnings exceeding expectations, raising full-year adjusted EPS guidance to at least $9.50. The company cited favorable medical cost trends and strong execution. Management highlighted progress in clinical quality, Medicaid expansion, and capital allocation, including a divestiture and a new joint venture. Humana expects 2027 Medicare Advantage membership growth and an 8%-9% medical cost trend, with risks and opportunities outlined.

finance.biggo.com
$HUMHighAI 8/10

[Humana Q3 2026 Earnings Call] Humana Lifts Full-Year EPS Guidance to at Least $9.50 as Medical Cost Trend Lands at Low End of 7%-8% Range

Humana Inc. raised its full-year 2026 adjusted EPS guidance to at least $9.50 per share from $9.00, citing favorable medical cost trends. The company reported strong STARS performance and plans to use excess funds for investments and shareholder returns. Humana also announced balance sheet improvements through divestitures and a new joint venture with BlackRock. Management expects 2027 Medicare Advantage membership growth and higher medical cost trends.

finance.biggo.com
$HUMMed

Humana Lifted Its Profit Forecast As Medical Costs Cooled

Humana raised its profit forecast due to lower medical costs, despite posting an adjusted quarterly loss. The company reported a 93.7% medical cost ratio, which may influence its Medicare Advantage pricing. Humana's individual Medicare Advantage membership grew 23% year-to-date, with a target of 25% growth by 2026 and a pretax margin of at least 3% by 2028.

finimize.com